NVCR - NovoCure Limited
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$33.50
DETAILS
HIGH:
$47.00
LOW:
$20.00
MEDIAN:
$33.50
CONSENSUS:
$33.50
UPSIDE:
86.53%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue | 655.4 | 605.2 | 509.3 | 537.8 | 535.0 | 494.4 | 351.3 | 248.1 | 177.0 | 82.9 | 33.1 | 15.5 | 10.4 |
| Cost of Revenue | 166.9 | 137.2 | 128.3 | 114.9 | 114.9 | 106.5 | 88.6 | 80.0 | 55.6 | 46.3 | 20.6 | 10.0 | 7.0 |
| Gross Profit | 488.5 | 468.0 | 381.1 | 423.0 | 420.2 | 387.9 | 262.7 | 168.0 | 121.4 | 36.6 | 12.5 | 5.5 | 3.3 |
| Operating Expenses | |||||||||||||
| R&D Expenses | 224.5 | 209.6 | 223.1 | 206.1 | 201.3 | 132.0 | 79.0 | 50.6 | 38.1 | 41.5 | 43.7 | 40.4 | 34.8 |
| SG&A Expenses | 417.7 | 428.9 | 390.9 | 306.4 | 263.2 | 225.5 | 184.6 | 151.1 | 122.6 | 110.5 | 72.7 | 45.2 | 33.0 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 642.3 | 638.5 | 614.7 | 512.5 | 464.5 | 357.5 | 263.6 | 201.7 | 160.7 | 151.9 | 116.5 | 85.6 | 67.8 |
| Operating Income | |||||||||||||
| Operating Income | (153.8) | (170.5) | (232.9) | (89.5) | (44.3) | 30.4 | (0.9) | (33.7) | (39.3) | (115.3) | (104.0) | (80.2) | (64.5) |
| Interest Expense | 0 | 11.7 | 4.9 | 8.1 | 8.8 | 18.1 | 14.6 | 16.9 | 11.7 | 6.9 | 2.9 | 0.2 | 12.7 |
| Interest Income | 18.1 | 51.0 | 46.0 | 15.8 | 1.1 | 5.8 | 6.7 | 4.6 | 2.0 | 1.2 | 0.1 | 0.1 | 0.3 |
| Profitability | |||||||||||||
| EBITDA | (119.0) | (109.6) | (177.5) | (67.9) | (38.4) | 44.8 | 13.4 | (23.4) | (29.1) | (108.9) | (101.1) | (78.2) | (63.1) |
| EBIT | (136.2) | (120.8) | (188.4) | (78.5) | (48.6) | 35.7 | 5.0 | (32.5) | (36.8) | (114.5) | (104.3) | (80.3) | (64.3) |
| Income Before Tax | (136.2) | (131.2) | (191.7) | (81.8) | (52.1) | 18.1 | (8.8) | (45.9) | (48.5) | (121.5) | (107.1) | (80.3) | (77.0) |
| Income Tax Expense | (0.0) | 37.5 | 15.3 | 10.7 | 6.3 | (1.7) | (1.6) | 17.6 | 13.2 | 10.4 | 4.4 | 0.4 | 0.4 |
| Net Income | (136.2) | (168.6) | (207.0) | (92.5) | (58.4) | 19.8 | (7.2) | (63.6) | (61.7) | (131.8) | (111.6) | (80.7) | (77.4) |
| Per Share Data | |||||||||||||
| EPS (Basic) | -1.22 | -1.56 | -1.95 | -0.88 | -0.56 | 0.20 | -0.07 | -0.69 | -0.70 | -1.54 | -1.34 | -1.12 | -6.43 |
| EPS (Diluted) | -1.22 | -1.56 | -1.95 | -0.88 | -0.56 | 0.18 | -0.07 | -0.69 | -0.70 | -1.54 | -1.34 | -1.12 | -6.43 |
| Shares Outstanding | 111.5 | 107.8 | 106.4 | 104.7 | 103.4 | 100.9 | 97.2 | 91.8 | 88.5 | 85.6 | 83.2 | 72.1 | 12.0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 103.4 | 163.8 | 240.8 | 115.3 | 209.6 | 246.2 | 179.4 | 140.6 | 78.6 | 99.8 |
| Short-Term Investments | 354.1 | 796.1 | 669.8 | 854.1 | 728.9 | 607.9 | 148.8 | 105.3 | 104.7 | 119.9 |
| Net Receivables | 115.3 | 102.1 | 77.1 | 86.3 | 97.4 | 100.5 | 64.0 | 36.5 | 29.6 | 6.3 |
| Inventory | 0 | 35.1 | 38.2 | 29.4 | 24.4 | 27.4 | 23.7 | 22.6 | 22.0 | 25.5 |
| Other Current Assets | 73.9 | 2.3 | 1.7 | 20.0 | 8.5 | 13.5 | 21.9 | 2.1 | 2.1 | 0.3 |
| Total Current Assets | 646.7 | 1,106.6 | 1,034.4 | 1,111.5 | 1,073.5 | 999.4 | 439.9 | 321.4 | 245.1 | 261.9 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 0 | 119.6 | 97.7 | 69.0 | 53.9 | 41.6 | 34.6 | 15.4 | 18.1 | 18.6 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 157.6 | 14.6 | 14.0 | 11.2 | 12.1 | 10.9 | 4.9 | 3.1 | 2.1 | 1.6 |
| Total Non-Current Assets | 157.6 | 134.2 | 111.7 | 80.1 | 66.0 | 52.5 | 39.5 | 18.4 | 20.2 | 20.2 |
| Total Assets | 804.3 | 1,240.8 | 1,146.1 | 1,191.6 | 1,139.5 | 1,052.0 | 479.4 | 339.8 | 265.3 | 282.1 |
| Current Liabilities | ||||||||||
| Account Payables | 122.2 | 105.1 | 94.4 | 85.2 | 72.6 | 53.6 | 36.9 | 26.7 | 17.2 | 18.4 |
| Short-Term Debt | 11.7 | 558.2 | 0 | 0 | 6.7 | 6.5 | 4.6 | 0 | 0 | 0 |
| Deferred Revenue | 15.9 | 14.2 | 16.2 | 18.0 | 17.8 | 17.8 | 11.8 | 8.8 | 5.0 | 2.3 |
| Other Current Liabilities | 9.0 | 0 | 0 | 0 | 0.2 | 0.1 | 0.1 | 12.3 | 5.6 | 5.6 |
| Total Current Liabilities | 223.2 | 756.4 | 179.1 | 158.8 | 142.6 | 113.6 | 86.3 | 64.6 | 50.2 | 36.9 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 236.7 | 97.3 | 568.8 | 565.5 | 562.2 | 429.9 | 149.4 | 149.3 | 97.3 | 96.2 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | (0.9) |
| Other Non-Current Liabilities | (37.7) | 7.0 | 8.3 | 4.6 | 4.7 | 5.5 | 4.0 | 3.7 | 4.2 | 6.6 |
| Total Non-Current Liabilities | 240.6 | 124.2 | 604.5 | 591.7 | 586.4 | 461.8 | 175.3 | 163.0 | 101.5 | 102.9 |
| Total Liabilities | 463.9 | 880.6 | 783.6 | 750.5 | 729.0 | 575.5 | 261.7 | 227.5 | 151.7 | 139.7 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (1,290.4) | (1,154.1) | (985.5) | (778.5) | (685.9) | (631.1) | (650.9) | (643.7) | (582.3) | (519.9) |
| Accumulated Other Comprehensive Income | (3.4) | (5.5) | (5.5) | (2.4) | (3.2) | (3.8) | (2.8) | (1.4) | (1.3) | (1.9) |
| Total Stockholders' Equity | 340.5 | 360.2 | 362.5 | 441.2 | 410.5 | 476.5 | 217.8 | 112.3 | 113.6 | 142.3 |
| Total Liabilities & Equity | 804.3 | 1,240.8 | 1,146.1 | 1,191.6 | 1,139.5 | 1,052.0 | 479.4 | 339.8 | 265.3 | 282.1 |
| Debt Metrics | ||||||||||
| Total Debt | 290 | 683.4 | 596.2 | 584.3 | 581.9 | 450.7 | 168.2 | 149.3 | 97.3 | 96.2 |
| Net Debt | 186.6 | 519.6 | 355.4 | 468.9 | 372.3 | 204.5 | (11.2) | 8.6 | 18.8 | (3.5) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (136.2) | (168.6) | (207.0) | (92.5) | (58.4) | 19.8 | (7.2) | (63.6) | (61.7) | (131.8) |
| Depreciation & Amortization | 14.7 | (14.4) | 11.0 | 10.6 | 10.3 | 9.2 | 8.5 | 9.0 | 7.7 | 5.7 |
| Stock-Based Compensation | 0 | 160.0 | 115.6 | 107.0 | 94.9 | 75.7 | 52.4 | 39.8 | 27.1 | 22.1 |
| Change in Working Capital | (15.1) | (4.3) | 29.6 | 11.8 | 29.1 | (8.5) | (24.3) | 11.4 | (6.8) | (9.4) |
| Other Non-Cash Items | 87.7 | 0.9 | (22.4) | (6.1) | 3.0 | 3.3 | (2.2) | 1.0 | 0.3 | 0.2 |
| Operating Cash Flow | (49.0) | (26.4) | (73.3) | 30.8 | 82.8 | 99.1 | 26.6 | (1.9) | (33.1) | (107.6) |
| Investing Activities | ||||||||||
| Capital Expenditure | (26.6) | (42.9) | (27.1) | (21.4) | (24.2) | (15.0) | (10.5) | (6.7) | (7.4) | (17.7) |
| Acquisitions | 0 | 0 | 0 | 118.6 | 120.7 | 457.9 | 41.2 | 3.8 | 0 | 0 |
| Purchases of Investments | (821.1) | (875.4) | (1,003.7) | (1,297.9) | (1,078.7) | (607.9) | (461.8) | (253.8) | (104.0) | (239.3) |
| Sales/Maturities of Investments | 1,285 | 778 | 1,215.0 | 1,179.3 | 958 | 150 | 420.7 | 255 | 120 | 270 |
| Other Investing Activities | 0 | 0 | 0 | (118.6) | (120.7) | (457.9) | (41.2) | (3.8) | (1.9) | (0.2) |
| Investing Cash Flow | 437.3 | (140.2) | 184.1 | (140.0) | (144.8) | (472.8) | (51.7) | (5.5) | 6.8 | 12.8 |
| Financing Activities | ||||||||||
| Net Debt Issuance | (461.0) | 84.0 | (0.0) | (0.0) | (0.0) | 408.4 | (0.0) | 49.1 | (0.1) | 72.8 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.1) | 2.2 | 11.4 | 10.3 | 21.2 | 28.4 | 59.2 | 18.5 | 3.7 | 1.7 |
| Financing Cash Flow | (451.3) | 90.3 | 15.8 | 15.5 | 25.7 | 440.2 | 61.7 | 69.4 | 5.2 | 75.1 |
| Cash Position | ||||||||||
| Net Change in Cash | (62.7) | (76.5) | 126.7 | (93.8) | (36.6) | 66.8 | 36.7 | 62.0 | (21.2) | (19.6) |
| Cash at Beginning | 166.1 | 242.6 | 115.8 | 209.6 | 246.2 | 179.4 | 142.8 | 80.7 | 99.8 | 119.4 |
| Cash at End | 103.4 | 166.1 | 242.6 | 115.8 | 209.6 | 246.2 | 179.4 | 142.8 | 78.6 | 99.8 |
| Free Cash Flow | (75.7) | (69.2) | (100.4) | 9.4 | 58.6 | 84.2 | 16.1 | (8.6) | (40.5) | (125.3) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 655.4 | 605.2 | 509.3 | 537.8 | 535.0 | 494.4 | 351.3 | 248.1 | 177.0 | 82.9 | 33.1 | 15.5 | 10.4 |
| Gross Profit | 488.5 | 468.0 | 381.1 | 423.0 | 420.2 | 387.9 | 262.7 | 168.0 | 121.4 | 36.6 | 12.5 | 5.5 | 3.3 |
| Operating Income | (153.8) | (170.5) | (232.9) | (89.5) | (44.3) | 30.4 | (0.9) | (33.7) | (39.3) | (115.3) | (104.0) | (80.2) | (64.5) |
| Net Income | (136.2) | (168.6) | (207.0) | (92.5) | (58.4) | 19.8 | (7.2) | (63.6) | (61.7) | (131.8) | (111.6) | (80.7) | (77.4) |
| EPS (Diluted) | -1.22 | -1.56 | -1.95 | -0.88 | -0.56 | 0.18 | -0.07 | -0.69 | -0.70 | -1.54 | -1.34 | -1.12 | -6.43 |
| Balance Sheet | |||||||||||||
| Cash & Equivalents | 103.4 | 163.8 | 240.8 | 115.3 | 209.6 | 246.2 | 179.4 | 140.6 | 78.6 | 99.8 | |||
| Total Assets | 804.3 | 1,240.8 | 1,146.1 | 1,191.6 | 1,139.5 | 1,052.0 | 479.4 | 339.8 | 265.3 | 282.1 | |||
| Total Debt | 290 | 683.4 | 596.2 | 584.3 | 581.9 | 450.7 | 168.2 | 149.3 | 97.3 | 96.2 | |||
| Stockholders' Equity | 340.5 | 360.2 | 362.5 | 441.2 | 410.5 | 476.5 | 217.8 | 112.3 | 113.6 | 142.3 | |||
| Cash Flow | |||||||||||||
| Operating Cash Flow | (49.0) | (26.4) | (73.3) | 30.8 | 82.8 | 99.1 | 26.6 | (1.9) | (33.1) | (107.6) | |||
| Capital Expenditure | (26.6) | (42.9) | (27.1) | (21.4) | (24.2) | (15.0) | (10.5) | (6.7) | (7.4) | (17.7) | |||
| Free Cash Flow | (75.7) | (69.2) | (100.4) | 9.4 | 58.6 | 84.2 | 16.1 | (8.6) | (40.5) | (125.3) | |||